F16-IL2 Fusion Protein

An immunocytokine of the human monoclonal antibody fragment F16 (scFv) against the extra-domain A1 of tenascin-C fused, via a short 5-amino acid linker, to a recombinant form of the human cytokine interleukin-2 (IL-2) with potential immunostimulating and antineoplastic activities. The monoclonal antibody portion of the F16-IL2 fusion protein binds to tumor cells expressing the tumor associated antigen (TAA) tenascin-C. In turn, the IL-2 moiety of the fusion protein stimulates natural killer (NK) cells, macrophages and neutrophils and induces T-cell antitumor cellular immune responses thereby selectively killing tenascin-C-expressing tumor cells. In addition, F16-IL2 may potentiate the cytotoxicity of other chemotherapeutic agents. Tenascin-C, a glycoprotein of the extracellular matrix, is expressed in many cancer cell types. (NCI Thesaurus)

YOU MAY ALSO LIKE

F12 wt Allele

Human F12 wild-type allele is located within 5q33-qter and is approximately 8 kb in length. This allele, which encodes coagulation factor XII…

F12 Gene

This gene is involved in blood coagulation and fibrinolysis.

F10 wt Allele

The F10 wt Allele is located in the vicinity of 13q34 and is approximately 27 kb in length. This allele, which encodes…

F10 Gene

This gene plays a role in proteolysis and blood clotting.

F1.2

The two peptides that can be released by proteolytic activation of prothrombin to thrombin. The level of these fragments is directly proportional…

F1 Particle

The portion of the mitochondrial ATP synthase that is found inside the matrix. This protein complex can catalyze the conversion of adenosine…